日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2

一项针对携带 ATM、BRCA1、BRCA2、PALB2 和 CHEK2 致病性变异的晚期胰腺癌患者的 Niraparib II 期试验

Huffman, Brandon M; Diossy, Miklos; Yurgelun, Matthew B; Horick, Nora; Li, Yvonne Y; Crowdis, Jett; Nguyen, Huy; Parmar, Kalindi; Kochupurakkal, Bose S; Vonk, Leonard; Lam, Helen; Ramsey, Kaitlyn; Andrews, Elizabeth; Loeb, Sarah C; Culnane, Leigh; Biller, Leah H; Bullock, Andrea J; Enzinger, Andrea; Giannakis, Marios; Jackson, Nadine A; Ng, Kimmie; Nowak, Jonathan A; Patel, Anuj K; Perez, Kimberly J; Rattani, Ahmed; Rubinson, Douglas A; Schlechter, Benjamin L; Singh, Harshabad; Cai, Mingyang; Raghavan, Srivatsan; Clark, Jefferey W; Peters, Mary Linton; Weipert, Caroline M; Wolpin, Brian M; D'Andrea, Alan D; Shapiro, Geoffrey I; Aguirre, Andrew J; Szallasi, Zoltan; Cleary, James M

A phase II study of ramucirumab and somatostatin analog therapy in patients with advanced neuroendocrine tumors

雷莫芦单抗联合生长抑素类似物治疗晚期神经内分泌肿瘤患者的II期研究

Perez, Kimberly; Kulke, Matthew H; Zheng, Hui; Allen, Jill; Clark, Jeffrey; Enzinger, Andrea C; Enzinger, Peter C; Johnson, Bruce E; McCleary, Nadine J; Parikh, Aparna; Patel, Anuj; Rubinson, Douglas; Yurgelun, Matthew B; Ramsey, Kaitlyn; Johnson, Emma; Graham, Christopher; Chan, Jennifer A

The Anthrax Toxin Lethal Factor in Solution Does Not Have the Protein's Crystallized Structure

溶液中的炭疽毒素致死因子不具有蛋白质的晶体结构。

Rubinson, Kenneth A; Kasianowicz, John J

The solution supramolecular structure of α2 → 8 polysialic acid suggests a structural cause for its low immunogenicity

α2→8多唾液酸的溶液超分子结构表明其低免疫原性可能源于其结构特性。

Rubinson, Kenneth A

Sotorasib Is a Pan-RASG12C Inhibitor Capable of Driving Clinical Response in NRASG12C Cancers

Sotorasib 是一种泛 RASG12C 抑制剂,能够促进 NRASG12C 癌症的临床反应

Douglas A Rubinson #, Noritaka Tanaka #, Ferran Fece de la Cruz, Kevin S Kapner, Michael H Rosenthal, Bryanna L Norden, Haley Barnes, Sara Ehnstrom, Alvin A Morales-Giron, Lauren K Brais, Christopher T Lemke, Andrew J Aguirre, Ryan B Corcoran

Protein biomarkers and alternatively methylated cell-free DNA detect early stage pancreatic cancer

蛋白质生物标志物和替代甲基化的游离DNA可检测早期胰腺癌

Ben-Ami, Roni; Wang, Qiao-Li; Zhang, Jinming; Supplee, Julianna G; Fahrmann, Johannes F; Lehmann-Werman, Roni; Brais, Lauren K; Nowak, Jonathan; Yuan, Chen; Loftus, Maureen; Babic, Ana; Irajizad, Ehsan; Davidi, Tal; Zick, Aviad; Hubert, Ayala; Neiman, Daniel; Piyanzin, Sheina; Gal-Rosenberg, Ofer; Horn, Amit; Shemer, Ruth; Glaser, Benjamin; Boos, Natalia; Jajoo, Kunal; Lee, Linda; Clancy, Thomas E; Rubinson, Douglas A; Ng, Kimmie; Chabot, John A; Kastrinos, Fay; Kluger, Michael; Aguirre, Andrew J; Jänne, Pasi A; Bardeesy, Nabeel; Stanger, Ben; O'Hara, Mark H; Till, Jacob; Maitra, Anirban; Carpenter, Erica L; Bullock, Andrea J; Genkinger, Jeanine; Hanash, Samir M; Paweletz, Cloud P; Dor, Yuval; Wolpin, Brian M

Clinical outcomes and ctDNA correlates for CAPOX BETR: a phase II trial of capecitabine, oxaliplatin, bevacizumab, trastuzumab in previously untreated advanced HER2+ gastroesophageal adenocarcinoma

CAPOX BETR 的临床结果和 ctDNA 相关性:一项卡培他滨、奥沙利铂、贝伐珠单抗、曲妥珠单抗治疗既往未接受治疗的晚期 HER2+ 胃食管腺癌的 II 期试验

Singh, Harshabad; Lowder, Kristen E; Kapner, Kevin; Kelly, Ronan J; Zheng, Hui; McCleary, Nadine Jackson; Abrams, Thomas A; Chan, Jennifer A; Regan, Eileen M; Klempner, Samuel J; Hannigan, Alison M; Remland, Joshua; Brais, Lauren K; Andrews, Elizabeth; Yurgelun, Matthew; Cleary, James M; Rubinson, Douglas A; Ritterhouse, Lauren L; Maron, Garrett; Aguirre, Andrew J; Meyerhardt, Jeffrey A; Gardecki, Emma; Lennerz, Jochen K; Wolpin, Brian M; Enzinger, Peter C

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders

帕博利珠单抗治疗晚期肛门鳞状细胞癌疗效的生物标志物:一项 II 期临床试验和长期缓解者队列研究的分析

Huffman, Brandon M; Singh, Harshabad; Ali, Lestat R; Horick, Nora; Wang, S Jennifer; Hoffman, Megan T; Metayer, Katherine A; Murray, Shayla; Bird, Alexandra; Abrams, Thomas A; Biller, Leah H; Chan, Jennifer A; Meyerhardt, Jeffrey A; McCleary, Nadine J; Goessling, Wolfram; Patel, Anuj K; Wisch, Jeffrey S; Yurgelun, Matthew B; Mouw, Kent; Reardon, Brendan; Van Allen, Eliezer M; Zerillo, Jessica A; Clark, Jeffrey W; Parikh, Aparna; Mayer, Robert J; Schlechter, Benjamin; Ng, Kimmie; Kumar, Sunil; Del Vecchio Fitz, Catherine; Kuperwasser, Charlotte; Hanna, Glenn J; Coveler, Andrew L; Rubinson, Douglas A; Welsh, Emma L; Pfaff, Kathleen; Rodig, Scott; Dougan, Stephanie K; Cleary, James M

RAS/RAF Comutation and ERBB2 Copy Number Modulates HER2 Heterogeneity and Responsiveness to HER2-directed Therapy in Colorectal Cancer

RAS/RAF 计算和 ERBB2 拷贝数调节结直肠癌中 HER2 异质性和对 HER2 靶向治疗的响应性

Harshabad Singh, Pranshu Sahgal, Kevin Kapner, Steven M Corsello, Hersh Gupta, Rahul Gujrathi, Yvonne Y Li, Andrew D Cherniack, Raquelle El Alam, Joseph Kerfoot, Elizabeth Andrews, Annette Lee, Chetan Nambiar, Alison M Hannigan, Joshua Remland, Lauren Brais, Meghan E Leahy, Douglas A Rubinson, Benja

Blockade of IL1β and PD1 with Combination Chemotherapy Reduces Systemic Myeloid Suppression in Metastatic Pancreatic Cancer with Heterogeneous Effects in the Tumor

IL1β 和 PD1 阻断与联合化疗可降低转移性胰腺癌的全身性髓系抑制,并对肿瘤产生异质性影响

Paul E Oberstein, Andressa Dias Costa #, Emily A Kawaler #, Victoire Cardot-Ruffino #, Osama E Rahma, Nina Beri, Harshabad Singh, Thomas A Abrams, Leah H Biller, James M Cleary, Peter Enzinger, Brandon M Huffman, Nadine J McCleary, Kimberly J Perez, Douglas A Rubinson, Benjamin L Schlechter, Rishi S